Cargando…
Nivolumab-associated DRESS in a genetic susceptible individual
The use of immune checkpoint inhibitors (ICIs) is rising exponentially in numerous cancers, but immune-related adverse events can occur. We report a rare case of high-grade drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome developed stepwise in a patient with gastric cancer afte...
Autores principales: | Ai, Luoyan, Gao, Jie, Zhao, Shihai, Li, Qian, Cui, Yue-Hong, Liu, Qing, Wu, Duojiao, Wang, Yimei, Jin, Xiaoshi, Ji, Yuan, Li, Jingjie, Yu, Yiyi, Liu, Tianshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488716/ https://www.ncbi.nlm.nih.gov/pubmed/34599025 http://dx.doi.org/10.1136/jitc-2021-002879 |
Ejemplares similares
-
Nivolumab-associated DRESS syndrome: A case report
por: Lu, Jessica, et al.
Publicado: (2019) -
Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report
por: Feng, Yi, et al.
Publicado: (2022) -
Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World
por: Zhang, Shilong, et al.
Publicado: (2022) -
Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway
por: Liu, Mengling, et al.
Publicado: (2022) -
Phase I study of adjuvant chemotherapy with nab‐paclitaxel and S‐1 for stage III Lauren's diffuse‐type gastric cancer after D2 resection (NORDICA study)
por: Cui, Yuehong, et al.
Publicado: (2022)